Most laboratory mouse strains including C57BL/6J do not produce detectable levels of pineal melatonin owing to deficits in enzymatic activity of arylalkylamine N-acetyltransferase (AANAT) and Nacetylserotonin O-methyl transferase (ASMT), two enzymes necessary for melatonin biosynthesis. Here we report that alleles segregating at these two loci in C3H/HeJ mice, an inbred strain producing melatonin, suppress the circadian period-lengthening effect of the Clock mutation. Through a functional mapping approach, we localize mouse Asmt to chromosome X and show that it, and the Aanat locus on chromosome 11, are significantly associated with pineal melatonin levels. Treatment of suprachiasmatic nucleus (SCN) explant cultures from Period2
C ircadian (from the Latin, meaning about a day) rhythms of biochemistry and physiology are innate to virtually all life forms (1, 2) . Cell autonomous circadian pacemakers drive these rhythms and synchronize them each day to environmental cues. In mammals, the suprachiasmatic nucleus (SCN) of the hypothalamus contains the central pacemaker that coordinates the local circadian clocks present in tissues throughout the body (3, 4) . The molecular clock mechanism within individual cells is composed of transcriptional/translational feedback loops and posttranslational processes (1, 5) . The bHLH-PAS transcription factors CLOCK and BMAL1 form the primary loop as they activate transcription of the Period (Per1 and Per2) and Cryptochrome (Cry1 and Cry2) genes (1, 6) . The PER and CRY proteins subsequently feed back to abrogate their own transcription by directly inhibiting the CLOCK:BMAL1 complex. A second feedback loop stabilizes the primary loop and is composed of REV-ERBα and RORa, two retinoic acid-related orphan receptors, which repress and activate, respectively, transcription of Bmal1. Whereas approximately a dozen genes involved in this timekeeping system have been identified in mammals, it is clear that other, as-yet unknown genes regulate key properties of circadian rhythms (7, 8) .
The SCN imparts daily entraining signals to circadian clocks in cells of peripheral tissues via neural connections and humoral factors (9, 10) . One well-characterized circadian rhythm synchronized by the SCN is the synthesis and release at night of the lipophilic pineal hormone melatonin (11) . Light information reaches the mammalian pineal gland through a multisynaptic pathway that begins with intrinsically photosensitive melanopsin-containing retinal ganglion cells, which project to the SCN via the retinohypothalamic tract, and ultimately terminates at sympathetic afferents of the pineal gland (12, 13) . Lesions of the SCN abolish the melatonin circadian rhythm (14) . Two high-affinity melatonin receptors, Mtnr1a and Mtnr1b, have been characterized, and both are expressed in the SCN (15) (16) (17) . This is interesting as it raises the possibility that melatonin may directly act to affect SCN output. Indeed, studies with Mtnr1a knockout mice show that this receptor mediates acute inhibition of SCN electrical activity by melatonin (18) . Furthermore, the phase-shifting effects of exogenous melatonin administration have been associated with the Mtnr1b receptor (19) .
Most of the commonly used laboratory mouse strains are deficient in pineal melatonin synthesis, likely as a result of compromised activity of one or both of the major enzymes in the melatonin biosynthesis pathway, AANAT and ASMT (also referred to as hydroxyindole O-methyltransferase, HIOMT) (20) (21) (22) (23) . While mapping the Clock mutation in mice, which lengthens the circadian period of the locomotor activity rhythm (24), we observed that the Clock/+ behavioral phenotype was significantly suppressed by the C3H/HeJ genetic background. A useful approach in studying the function of a gene is the identification of other loci that modify its mutant phenotype using quantitative trait locus (QTL) mapping (25) . For example, the effectiveness of this approach has been demonstrated previously by the identification of Mom-1 (Modifier of Min) in which the expression of Min (multiple intestinal neoplasia) was dramatically affected by genetic background (26) . Here we used the QTL modifier approach to map loci that suppress the free-running circadian period of locomotor activity in [(C3H/HeJ × C57BL/6J
Clock/+ )F 1 × C57BL/6J]N 2 Clock/+ mutant mice, and identify a genetic interaction between the melatonin biosynthetic pathway and the circadian clock mechanism in mammals.
Results
Effect of Strain Background on Circadian Behavior of Clock/+ Mice.
The Clock mutation was originally induced in the coisogenic C57BL/6J background by N-ethyl-N-nitrosourea (ENU) mutagenesis and is caused by a splicing mutation that deletes exon 19 (24, 27) . This mutation lengthens the circadian free-running period by~1 h in heterozygotes and by~4 h in homozygous Clock mutant mice followed by arrhythmicity in constant darkness (DD). We observed that the circadian behavioral phenotype in Clock/+ animals is often suppressed by crossing to the C3H/HeJ background (Fig. 1A) . The free-running period of Clock/+ on a coisogenic C57BL/6J background is 24.3 ± 0.13 h (mean ± SD), whereas that from (C3H/HeJ × C57BL/6J)F 1 hybrids is 23.6 ± 0.22 h, a reduction in mutant period of almost 1 h. This period difference was not observed in wild-type littermates from the C57BL/6J (23.6 ± 0.23 h) and (C3H/HeJ × C57BL/6J)F 1 (23.6 ± 0.11 h) crosses (Fig. 1B) . This suggests that the C3H/HeJ strain carries genetic modifiers, which dominantly suppress the Clock mutant phenotype, but which have no discernible effect on period in wild-type littermates.
We examined the locomotor activity rhythms of [(C3H/HeJ × C57BL/6J)F 1 × C57BL/6J]N 2 Clock/+ mice to test whether these modifiers segregate in an N 2 backcross population (Fig. 1C) . Phenotypic variation among [(C3H/HeJ × C57BL/6J)F 1 × C57BL/6J] N 2 progeny was greater than among the parental animals, C57BL/6J and [(C3H/HeJ × C57BL/6J)F 1 . Some mice expressed phenotypes similar to Clock/+ from the C57BL/6J coisogenic background whereas others expressed phenotypes similar to Clock/+ from the (C3H/HeJ × C57BL/6J)F 1 background. The larger phenotypic variation in the N 2 population suggests that Clock suppressors segregate in this population.
Mapping of Clock Suppressors. To map modifier loci, we initially genotyped Clock/+ mice from a [(C3H/HeJ × C57BL/6J)F 1 × C57BL/6J]N 2 panel with simple sequence length polymorphism (SSLP) markers distributed over the genome (Table S1 ). QTL analysis detected a significant association of period phenotype on distal chromosome 11 (LOD = 4.5) and a weak association on chromosome X (LOD = 2.3) ( Fig. 2A) . To confirm and strengthen these results, chromosomes 11 and X were analyzed in additional Clock/+ mice (total n = 96) from the [(C3H/HeJ × C57BL/6J)F 1 × C57BL/6J]N 2 cross (Fig. 2B ). The effect of each locus is shown (Fig. 2C ).
Aanat and Asmt Are Candidate Suppressors of Clock. We determined that a potential candidate gene for the QTL on the distal end of chromosome 11 is Aanat. This enzyme is deficient in C57BL/6J mice, but functional in the C3H/HeJ inbred strain (21, 28) . We reasoned that if Aanat polymorphisms are responsible for the chromosome 11 QTL, pineal melatonin itself may modify the circadian free-running period of Clock/+ mice. Furthermore, the Asmt locus should also be associated with the circadian free-running period of Clock/+ mice. We therefore functionally mapped the Asmt locus in mice using pineal melatonin as a phenotype in 61 [(C3H/HeJ × C57BL/6J)F 1 × C57BL/6J]N 2 progeny and 66 [(BALB/cJ × C3H/HeJ)F 1 × BALB/cJ]N 2 progeny-all wild-type animals. The distribution of pineal melatonin content of the 127 mice examined is skewed toward the low range (Fig. 3A) . This suggests that the pineal melatonin content in this population is determined by multiple loci. Among the mice with melatonin content >100 pg/pineal, we genotyped 9 mice (5 from the C57BL/ 6J × C3H/HeJ cross and 4 from the BALB/cJ × C3H/HeJ cross) with a mouse SNP linkage panel (29) . We found that high mela-
Wild Type
Clock/+ tonin content was tightly linked to two loci-one on the distal end of chromosome 11 (Aanat) and another at the distal end of chromosome X (Fig. 3B) . We then genotyped the remainder of the population for the two loci and found in both crosses that the pineal melatonin content phenotype was highly associated with the genotype of these two loci. Mice carrying C3H alleles at both loci had higher pineal melatonin content than those lacking C3H alleles at either locus. This result demonstrates that Asmt maps to the distal end of chromosome X.
To determine whether pineal melatonin content is also determined by Aanat and Asmt in the Clock/+ background, we (Fig. 3C) . Mice carrying C3H alleles at both loci produced higher levels of melatonin compared to those lacking C3H alleles at either locus. Mice carrying C3H alleles only at one of the two loci produced detectable levels of melatonin, but the amount was far lower than animals with C3H alleles at both loci. With respect to circadian period, Clock/+ mice carrying C3H alleles at Aanat and Asmt expressed a significantly shorter period than ones lacking C3H alleles at either locus (Fig. 3D) . These observations suggest that melatonin is the causative agent that suppresses the Clock phenotype.
Complementation in SCN Explant
Luc Clock/+ mice with melatonin or the melatonin receptorspecific agonist, ramelteon (30) . In Clock/+ SCN, the circadian period of bioluminescence was shortened by the presence of either melatonin or ramelteon (Fig. 4A) , just as the presence of functional AANAT and ASMT in vivo shortens the period of the behavioral rhythm in Clock/+ mice (Fig. 3D) . Melatonin treatment shortened circadian period in Clock/+ SCN with an EC 50 of 106 pM whereas ramelteon had an EC 50 of 0.217 pM (Fig. 4B) . These doses are well within the range for specific melatonin receptor activation (31) . By contrast, neither melatonin nor ramelteon affected the circadian period of SCN explants from wild-type mice. In addition, there were no effects of either drug on the amplitude of rhythms in Clock/+ or wild-type mice. In conclusion, treatment with either melatonin or ramelteon phenocopies the genetic sup- 
Discussion
It has been reported that when melatonin or its receptor agonists are present in circumstances under which the master circadian pacemaker is compromised, such as in aging or in simulated jet-lag paradigms (32) (33) (34) , the effects of melatonin become more apparent. That an effect of melatonin on circadian free-running period is detectable only in Clock/+ mice (genetically compromised circadian system), but not in wild-type animals, affirms this idea. Compensatory mechanisms may obscure the function of melatonin receptor signaling in the SCN in mammals. Thus, it will be of interest to test whether the circadian behavior of other clock mutants (e.g., Cry or Per mutants) are affected by melatonin.
The possibility that melatonin suppresses the effects of the Clock mutation in a strain-specific manner has been suggested by others (35) . When the Clock mutation is carried on the melatonin-producing CBA inbred strain, fewer homozygous mutant mice become arrhythmic in DD compared to homozygous mutants of a melatonindeficient inbred strain. Consistent with our results, Kennaway et al. observed no obvious differences in circadian behavior in wild-type mice from melatonin-producing and melatonin-deficient inbred strains. Although it is possible that the CBA strain segregates genetic loci in addition to Aanat and Asmt, which affect the Clock mutant phenotype, the Kennaway et al. report supports our findings.
To date, two melatonin receptors, Mtrn1a and Mtrn1b, have been identified in mammals (16, 17) , and both are expressed in the SCN. Melatonin has two distinct effects on the SCN: acute inhibition and phase shifting of SCN electrical activity (18, 19) . The effect of melatonin on phase shifting of the circadian rhythm in the SCN is mediated through protein kinase C activation (36) . Although some studies report that melatonin can affect clock gene expression in the SCN (37) (38) (39) , the signal transduction pathway from melatonin to the core clock remains to be defined. Interestingly, protein kinase C-mediated phosphorylation of CLOCK has been implicated in the resetting of circadian rhythms (40) , and RACK1 and protein kinase Cα have been shown to interact with BMAL1 in a circadian manner (41) . Thus, it is conceivable that melatonin-induced activation of protein kinase C could ultimately affect CLOCK and BMAL1 to suppress the Clock mutation. Recent work has shown that phosphorylation of CLOCKΔ19 mutant protein is reduced relative to wildtype CLOCK, leading to its stabilization (42) . Thus, melatonin could differentially affect CLOCKΔ19 phosphorylation to rescue this defect, which could explain at least in part the selective suppression of the Clock mutant phenotype.
Our results clearly demonstrate that the effect of melatonin on circadian free-running period is genetically determined in mice. Several studies have reported that polymorphisms in clock genes can affect human sleep phenotypes (2). Human genetic variation, however, has not been considered before treatment with melatonin is initiated. Thus, treatment with melatonin or related pharmaceutical compounds such as ramelteon for insomnia (32) or agomelatonine for depression (43) may be more efficacious in some cases by assessing clock gene polymorphisms in patients. Finally, the Clock mutation has also been shown to be associated with metabolic syndrome in mice (44) . It is therefore interesting that the melatonin receptor 1B (MTNR1B) gene has been strongly associated with fasting serum glucose levels in humans (45) (46) (47) . Perhaps, the suppressive effects of melatonin reported here may also have relevance to other phenotypes such as metabolism.
Materials and Methods
Animals. All animal care and experimental treatments were approved and performed in strict accordance with Northwestern University and University of Texas Southwestern Medical Center guidelines for animal care and use. Animals were raised in a 12-h light/12-h dark cycle (LD 12:12) from birth. After weaning, they were group housed (1-5 mice/cage).
Wheel-Running Behavior Assay. At 8-12 weeks of age, mice were transferred to individual cages equipped with running wheels and housed in LD 12:12 conditions. After a minimum of 7 days, animals were transferred to DD conditions for 3 weeks.
Clock Suppressor Mapping Cross. [(C3H/HeJ × C57BL/6J)F 1 × C57BL/6J]N 2 Clock/+ mice were bred from (C3H/HeJ × C57BL/6J)F 1 Clock/+ × C57BL/6J wild-type mice. Only Clock/+ mice were wheel tested.
ASMT Mapping Cross. [(C3H/HeJ × C57BL/6J)F 1 × C57BL/6J]N 2 and [(BALB/cJ × C3H/HeJ)F 1 × BALB/cJ]N 2 progeny were created for the ASMT mapping cross. They were all wild types. We also created [(C3H/HeJ × C57BL/6J)F 1 × C57BL/ 6J]N 2 Clock/+ mice from (C3H/HeJ × C57BL/6J)F 1 wild type × C57BL/6J Clock homozygotes. All progeny were Clock/+.
Per2
Luc Mice. The Per2 Luc Clock/+ mice used in this study were maintained on the C57BL/6J genetic background at Northwestern University. The genotyping protocol was described previously (48) .
Clock Genotyping. Genomic DNA was prepared by phenol-chloroform extraction from tail biopsies. Genotypingprimers usedwere: forward 5′-TACCAGCTGCTAATGTCCAGTG-3′; reverse 5′-TACATTGGGCTAGCCTTCCTAAG-3′. PCR conditions were 95°C for 2 min followed by 32 cycles of 95°C for 15 s, 55°C for 30 s, and 72°C for 15 s. Following amplification, PCR products were digested with 2 units of HincII for 2 h at 37°C. After restriction digestion, PCR products were resolved on 4% agarose gels. The Clock mutant allele was identified as an~70-bp product, whereas wildtype animals were identified by the presence of bands at~50 and~20 bp.
Free-Running Period Calculation. The free running period was calculated using a χ 2 periodogram as described previously (7).
Genomewide QTL Analysis. SSLP markers used in this study are listed in Table  S1 . The genotyping protocol has been described previously (7) .
QTL Analysis. QTL analysis was performed as described R/qtl (http://www.rqtl.org/).
High-Resolution Mapping of Asmt Locus. Tail DNA was extracted using Gentra Puregene Mouse Tail kit. Genotyping was performed at Harvard University Partners Center for Genetics and Genomics with their custom SNP panel (29) .
Pineal Collection and Melatonin Assay. Mice were raised in LD 12:12 conditions. Mice were killed, decapitated, and enucleated under infrared light at ZT22 (~10 h after lights off). Pineal glands were removed under a dissecting microscope and then frozen on dry ice. The pineal samples were maintained at -80°C until use. Individual pineal glands were dispersed by sonication in 200 μL of PBS containing 0.1% gelatin. The melatonin levels in 20-μL aliquots of each sample were determined by RIA as previously described (49) .
Aanat and Asmt Genotyping. We used a 3′ end primer mismatch method (50) whereby we introduced an artificial mismatch at the third position from the end of the 3′ end of the primer to obtain more significant allele detection than a mismatch at the final 3′ nucleotide alone (51) . All reactions were prepared with the ABI SYBR Green PCR kit and carried out real-time PCR on an ABI 7700 with the following conditions: 95°C for 10 min followed by 40 cycles of 95°C for 10 s, and 60°C for 30 s. The primers were as follows: Aanat. Aanat-nonC3H: 5′-CCAGCATGACCCAGTCTCAT-3′, Aanat-C3H: 5′-CCA GCATGACCCAGTCTCAC-3′, Aanat-R: 5′-CCCGAGCTGAGAGCTTTTTA-3′. Asmt. rs13484098-nonC3H: 5′-CAACAAGGATTTCACCACTAA-3′, rs13484098-C3H: 5′-CAACAAGGATTTCACCACTAC-3′, rs13484098-R: 5′-TGGGCCCATAA-TAAGCAAAG-3′. SCN Explant Culture. SCN slice culture was performed as described (48) . The bioluminescence data over time was recorded using a LumiCycle apparatus (Actimetrics). All bioluminescence analyses were performed with the LumiCycle Analysis program as described previously (48) .
ACKNOWLEDGMENTS. This work is supported by Takeda Research Grant 07-030R (to K.S.), National Institutes of Health (NIH) Grant R01 MH61461 (to C.B. G.), NIH Grant U01 MH61915 (to J.S.T.), and Silvio O. Conte Center NIH Grant P50 MH074924 (to C.B.G. and J.S.T.). J.S.T. is an investigator and V.K. was an associate in the Howard Hughes Medical Institute.
